ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2025
Relationship Between Chronic Inflammatory Indicators and Diabetic Peripheral Neuropathy in Hospitalized Elderly Patients with Type 2 Diabetes.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A Systematic Review of Lifestyle Interventions for Neuropathy and Neuropathic Pain: Alcohol Consumption and Avoidance.Brain sciences · 2026Review
- Phenotypic heterogeneity of type 2 diabetes and risks of complications with a tree-like representation.Cardiovascular diabetology · 2026Article
- Blood Urea Nitrogen to Albumin Ratio is Associated with Diabetic Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
- Clinical Significance of Serum CCR2 and IDO1 in Diabetic Peripheral Neuropathy.Diabetes, metabolic syndrome and obesity : targets and therapy · 2026Article
- A Nationwide Study on the Prevalence of Peripheral Neuropathy in Patients with Type 2 Diabetes Mellitus in Greece-The PRENEDIG Study.Journal of clinical medicine · 2025Article
- C5L2 gene polymorphisms and their functional interaction with metabolic-inflammatory networks in T2DM-associated CHD: insights from an integrative genetic and clinical analysis in a Chinese population.Frontiers in cardiovascular medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Investigate the correlation between chronic inflammatory indicators and DPN in hospitalized elderly patients with Type 2 diabetes mellitus (T2DM), and to build a prediction model to provide scientific basis for early identification of high-risk groups. Patients and Methods: Clinical data of 270 elderly T2DM patients hospitalized in the People's Hospital of Ningxia Hui Autonomous Region from January 2021 to December 2024 were selected and classified into a diabetic peripheral neuropathy group (DPN, n=163) and a non-diabetic peripheral neuropathy group (NDPN, n=107) depending on the presence of DPN. Clinical features, biochemical indicators and peripheral blood inflammatory indicators (PLR, NLR, MLR, SII, SIRI) of patients were collected, and a predictive model was constructed by logistic regression analysis. Results: The age, duration of diabetes, retinopathy, HbA1c, fasting blood glucose (FBG) and 2hPPG in DPN group were all higher than those in nonDPN group (P<0.05). In addition, the levels of PLR, NLR, MLR, SII and SIRI in DPN group were significantly higher than those in NDPN group (P<0.05). Multivariate Logistic regression analysis showed that the duration of diabetes, accompanying retinopathy, HbA1c and NLR were independent risk factors for DPN. The area under ROC curve (AUC) of the combined predictor constructed based on these factors was 0.802, which showed good prediction efficiency. Conclusion: Chronic inflammatory indicators such as PLR, NLR, MLR, SII and SIRI are closely related to elderly T2DM patients with DPN. Comprehensive evaluation of these indicators and key factors such as diabetes course can effectively predict the risk of elderly T2DM patients with DPN, which is conducive to early intervention and management, thereby improving patient prognosis. Reduce hospitalization rates and medical costs. This study provides a new perspective for understanding the role of chronic inflammation in DPN and lays the foundation for further research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.